Literature DB >> 31805016

Colonic Manifestations and Complications Are Relatively Under-Reported in Systemic Sclerosis: A Systematic Review.

Justin B Brandler1, Seth Sweetser1, Katayoun Khoshbin1, Mary Babameto1, Larry J Prokop2, Michael Camilleri1.   

Abstract

OBJECTIVES: Although systemic sclerosis (SSc) is known to affect the gastrointestinal (GI) tract, most of the literature focuses on esophageal, small intestinal, or anorectal manifestations. There have been no reviews focused on large bowel SSc complications in over 30 years. The aim of this study is to perform a systematic review of colonic manifestations and complications of SSc.
METHODS: An experienced librarian conducted a search of databases, including English and Spanish articles. The search used keywords including "systemic sclerosis," "scleroderma," and "colon." A systematic review was performed using Preferred Reporting Items for Systematic Review and Meta-Analyses guidelines. Case reports/series were screened for validity by adapting from criteria published elsewhere.
RESULTS: Of 1,890 articles, 74 met selection criteria. Fifty-nine of the 77 articles were case reports/series. The most common article topics on colonic SSc complications were constipation/dysmotility (15), colonic volvulus (8), inflammatory bowel disease (7), microscopic colitis (6), megacolon (6), and telangiectasia (6). Colonic manifestations constituted 24% of articles on GI complications of SSc. There were a total of 85 cases (84% women, with a median age of onset of colon complication of 52 years). Limited cutaneous SSc phenotype (65.6%) was more common than diffuse (26.2%). Patients frequently had poor outcomes with high mortality related to colonic complications (27%). Recent studies explore contemporary topics such as the microbiome in SSc and prucalopride for chronic constipation in SSc. DISCUSSION: Colonic complications comprise a large proportion of the published reports on GI symptoms afflicting patients with SSc and require raised diagnostic suspicion and deliberate action to avoid potentially serious complications including death.

Entities:  

Year:  2019        PMID: 31805016     DOI: 10.14309/ajg.0000000000000397

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  10 in total

Review 1.  Gastrointestinal involvement in systemic sclerosis: pathogenesis, assessment and treatment.

Authors:  Elizabeth R Volkmann; Zsuzsanna McMahan
Journal:  Curr Opin Rheumatol       Date:  2022-08-19       Impact factor: 4.941

Review 2.  Management of scleroderma gastrointestinal disease: Lights and shadows.

Authors:  Jenice X Cheah; Dinesh Khanna; Zsuzsanna H McMahan
Journal:  J Scleroderma Relat Disord       Date:  2022-04-19

Review 3.  An Update on Systemic Sclerosis and its Perioperative Management.

Authors:  Zyad J Carr; John Klick; Brittany J McDowell; Jean G Charchaflieh; Kunal Karamchandani
Journal:  Curr Anesthesiol Rep       Date:  2020-08-29

4.  Clinical Assessment of Gastrointestinal Involvement in Patients with Systemic Sclerosis.

Authors:  Timothy Kaniecki; Tsion Abdi; Zsuzsanna H McMahan
Journal:  Med Res Arch       Date:  2020-10-29

5.  Relationship Between Gastrointestinal Transit, Medsger Gastrointestinal Severity, and University of California-Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract 2.0 Symptoms in Patients With Systemic Sclerosis.

Authors:  Zsuzsanna H McMahan; Ana E Tucker; Jamie Perin; Elizabeth R Volkmann; Subhash Kulkarni; Harvey A Ziessman; Pankaj J Pasricha; Fredrick M Wigley
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-01-25       Impact factor: 4.794

6.  Considerations for a combined index for limited cutaneous systemic sclerosis to support drug development and improve outcomes.

Authors:  Alain Lescoat; Susan L Murphy; David Roofeh; John D Pauling; Michael Hughes; Robert Sandler; François Zimmermann; Rachel Wessel; Whitney Townsend; Lorinda Chung; Christopher P Denton; Peter A Merkel; Virginia Steen; Yannick Allanore; Francesco Del Galdo; Dominique Godard; David Cella; Sue Farrington; Maya H Buch; Dinesh Khanna
Journal:  J Scleroderma Relat Disord       Date:  2020-10-05

7.  Linaclotide for the treatment of refractory lower bowel manifestations of systemic sclerosis.

Authors:  Eric J Dein; Fredrick M Wigley; Zsuzsanna H McMahan
Journal:  BMC Gastroenterol       Date:  2021-04-15       Impact factor: 3.067

Review 8.  The Involvement of Smooth Muscle, Striated Muscle, and the Myocardium in Scleroderma: A Review.

Authors:  Ioana Bratoiu; Alexandra Maria Burlui; Anca Cardoneanu; Luana Andreea Macovei; Patricia Richter; Gabriela Rusu-Zota; Ciprian Rezus; Minerva Codruta Badescu; Andreea Szalontay; Elena Rezus
Journal:  Int J Mol Sci       Date:  2022-10-09       Impact factor: 6.208

9.  Managing gastrointestinal complications in patients with systemic sclerosis.

Authors:  Z H McMahan; D Khanna
Journal:  Curr Treat Options Gastroenterol       Date:  2020-11-13

10.  Slow Colonic Transit in Systemic Sclerosis: An Objective Assessment of Risk Factors and Clinical Phenotype.

Authors:  Jenice X Cheah; Jamie Perin; Elizabeth R Volkmann; Laura K Hummers; Pankaj J Pasricha; Fredrick M Wigley; Zsuzsanna H McMahan
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-08-09       Impact factor: 5.178

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.